000 | 01719 a2200481 4500 | ||
---|---|---|---|
005 | 20250514232450.0 | ||
264 | 0 | _c20060531 | |
008 | 200605s 0 0 eng d | ||
022 | _a0302-2838 | ||
024 | 7 |
_a10.1016/j.eururo.2005.04.011 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRiedl, Claus R | |
245 | 0 | 0 |
_aLiposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: a randomized placebo-controlled double-blind prospective clinical study. _h[electronic resource] |
260 |
_bEuropean urology _cOct 2005 |
||
300 |
_a656-61 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aDupuytren Contracture _xdrug therapy |
650 | 0 | 4 |
_aFree Radical Scavengers _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLiposomes |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPain Measurement |
650 | 0 | 4 | _aPatient Satisfaction |
650 | 0 | 4 |
_aPenile Erection _xdrug effects |
650 | 0 | 4 |
_aPenile Induration _xdrug therapy |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aSuperoxide Dismutase _xadministration & dosage |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aSternig, Peter | |
700 | 1 | _aGallé, Günter | |
700 | 1 | _aLangmann, Florian | |
700 | 1 | _aVcelar, Brigitta | |
700 | 1 | _aVorauer, Karola | |
700 | 1 | _aWagner, Andreas | |
700 | 1 | _aKatinger, Hermann | |
700 | 1 | _aPflüger, Heinz | |
773 | 0 |
_tEuropean urology _gvol. 48 _gno. 4 _gp. 656-61 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eururo.2005.04.011 _zAvailable from publisher's website |
999 |
_c15640296 _d15640296 |